Genedrive plc (LON:GDR), a molecular diagnostics company, saw its share price climb by 13.6% during mid-day trading on Tuesday. The stock reached a high of GBX 4.35 (£0.04) before settling at the same price. Trading volume was significantly higher than usual, reaching 28,617,904 shares, representing a 119% increase from the average daily volume of 13,039,475 shares. This surge in activity followed a closing price of GBX 3.83 (£0.04) the previous day.
Company Overview
Genedrive plc has a market capitalisation of £5.93 million, a price-to-earnings ratio of -99.65, and a beta of 0.04. The company's fifty-day simple moving average sits at GBX 2.10 (£0.02), while its 200-day simple moving average stands at GBX 4.10 (£0.04). Furthermore, Genedrive boasts a strong financial position, with a quick ratio of 5.52, a current ratio of 1.63, and a debt-to-equity ratio of 8.57.
About Genedrive
Genedrive plc is a leading player in the molecular diagnostics field, dedicated to developing and commercialising cutting-edge point-of-need diagnostics platforms. Their expertise spans infectious diseases, genotyping, pathogen detection, and other critical medical areas. The company's flagship product is the Genedrive system, a rapid thermocycler and signal detection system that forms the backbone of their semi-automated platform used for qualitative in vitro molecular diagnostic tests. Notably, Genedrive also offers the Genedrive CYP2C19 ID Kit, a point-of-care test designed for rapid CYP2C19 genotyping in time-sensitive emergency care situations.
Stay Informed:
To stay up-to-date on the latest news and analyst ratings for Genedrive and related companies, sign up for MarketBeat.com's FREE daily email newsletter. Simply enter your email address below to receive a concise daily summary of the latest market insights.